logo-loader
RNS
OptiBiotix Health PLC

OptiBiotix Health - New Investor Website

RNS Number : 5070P
OptiBiotix Health PLC
20 January 2026
 

OptiBiotix Health plc

("OptiBiotix" or the "Company" or the "Group")

 

New Investor Website

OptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces the launch of a new interactive investor website. The new investor website brings all OptiBiotix content including corporate, commercial and research into a single platform to better inform and engage with prospective and existing investors and other stakeholders. The website includes:

●     Announcements (RNS and Reach)

●     Annual and Interim reports

●     Investor presentations, podcasts and video updates

●     Research publications, product and technology overviews

●     Interviews with the CEO

●     Interviews and videos with research/ industry partners on its technology and products

 

The website provides users with the ability to ask the management team questions to provide context on announcements including progress or concerns via an interactive portal which will be monitored and responded to in a timely manner.  The overall aim is to give existing and prospective shareholders the opportunity to engage directly with the management team and have access to reliable information on which they can make a judgement. We would encourage all existing shareholders and prospective investors to sign up to the website (it should take less than one minute) and use it as your primary interface and information source for the business.

How to sign up for the OptiBiotix investor website:

1.    Visit www.optibiotix.com 

2.    Follow the prompts on the top right-hand side of the website marked SIGN UP

3.    Complete your account profile (name/email)

 

Stephen O'Hara, Chief Executive Officer, commented:

"The Board is keen to improve communications with our shareholders and give them access to reliable information on which to make their investment decisions. This new 'InvestorHub' enables us to discuss commercial progress with partners, share development progress and launch plans for our second-generation products like SweetBiotix, in more depth and context than is possible through RNS announcements alone, while remaining fully compliant with market disclosure obligations.

We encourage all stakeholders to explore the site, engage with our content, and share their questions and feedback. Your input is invaluable as we continue refining our communication channels and building a profitable and valuable business."

 

Ends

 

Engage with the OptiBiotix management team directly by asking questions, watching video summaries and seeing what other shareholders have to say.

Navigate to our Interactive Investor website here: https://optibiotix.com/link/P2zk3P

Subscribe to the new website to get regular updates here:  https://optibiotix.com/auth/signup

For further enquiries, please visit www.optibiotix.com or contact:

OptiBiotix Health PLC

Neil Davidson, Chairman

Stephen O'Hara, Chief Executive

 

We encourage all investors to share questions on this announcement via our investor website.

https://optibiotix.com/announcements

 

 

 

About OptiBiotix - www.optibiotix.com

OptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), OptiBiotix Health has developed a range of technologies and commercialised products which modulate the human microbiome to help prevent and manage human disease.  Since the Group's inception it has created a wide range of microbiome-based ingredients and products including prebiotic products like SlimBiome®, WellBiome®, SweetBiotix® and Microbiome Modulators within its core OptiBiotix Health plc (OPTI) business, but also skincare through its holdings in SkinBioTherapeutics PLC (SBTX), and probiotics through ProBiotix Health plc (PBX). These companies create a diverse portfolio of technologies and products in an emerging area of healthcare that is of growing interest in consumer markets throughout the world.

This communication is a "Reach" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAKZGMMRLRGVZM
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not registered in any category of registration under the securities legislation of any province or territory of Canada. Nothing in this record constitutes "advice" concerning investing in, buying, or selling a security within the meaning of applicable Canadian securities legislation. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after obtaining advice from a registrant authorised under the securities legislation of your province or territory.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship is for news distribution and media services only and does not determine, influence, or shape the editorial content produced.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

4 min read